Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-Defibrillators
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients
2011
The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation
1998
Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction
2013
Complications of cardiac implants: handling device infections
2012
Infections of Cardiac Implantable Electronic Devices
2012
Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease
2012
Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study
2010
Complete removal as a routine treatment for any cardiovascular implantable electronic device–associated infection
2011
Infective endocarditis
2015
Update on Cardiovascular Implantable Electronic Device Infections and Their Management
2010
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Clinical Features and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Staphylococcal Species
2012
Radiolabeled WBC Scintigraphy in the Diagnostic Workup of Patients With Suspected Device-Related Infections
2013
Infections of Cardiovascular Implantable Electronic Devices
2012
Cardiac implantable electronic device infections: Presentation, management, and patient outcomes
2010
Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects
2012
Effects of simulated left bundle branch block on QRST time-integral values of 12-lead electrocardiograms in patients with and without prior anterior wall myocardial infarction
1992 StandoutNobel
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Risk factors and time delay associated with cardiac device infections: Leiden device registry
2008
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Device‐Related Infection Among Patients With Pacemakers and Implantable Defibrillators: Incidence, Risk Factors, and Consequences
2010
Atrial fibrillation: current knowledge and recommendations for management*1
1998
Candida Infective Endocarditis
2009
Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines
2010
Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population
2012
Diagnosis, management and outcome of Candida endocarditis
2012
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management
2009
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
1990 Standout
Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis
2012
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Sequence of epicardial repolarisation and configuration of the T wave.
1988
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Slow and long-lasting modulation of myocardial repolarization produced by ectopic activation in isolated rabbit hearts. Evidence for cardiac "memory".
1989
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Persistent T-wave changes after alteration of the ventricular activation sequence. New insights into cellular mechanisms of 'cardiac memory'.
1993
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac 'memory'.
1992
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Prosthetic Joint Infection
2014 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015
Outcomes in Patients With Cardiovascular Implantable Electronic Devices and Bacteremia Caused by Gram-Positive Cocci Other Than Staphylococcus Aureus
2010
The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients.
2012
Works of C Barnay being referenced
Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry
2013
Long‐Term Follow‐up of Atrioventricular Junctional Transcatheter Electrical Ablation
1988
Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions
2007
Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register
2010
Wolff-Parkinson-White syndrome: T wave abnormalities during normal pathway conduction
1981
Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators
2007